These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3581706)

  • 41. Polymyalgia rheumatica and giant-cell arteritis.
    Salvarani C; Cantini F; Boiardi L; Hunder GG
    N Engl J Med; 2002 Jul; 347(4):261-71. PubMed ID: 12140303
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
    Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis.
    Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
    Ann Intern Med; 1994 Oct; 121(7):484-91. PubMed ID: 8067646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study.
    Schmidt J; Duhaut P; Bourgeois AM; Salle V; Smail A; Chatelain D; Betsou F; Mazière JC; Ducroix JP;
    Rheumatology (Oxford); 2009 Feb; 48(2):158-9. PubMed ID: 19098302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD8+ lymphocyte subset in polymyalgia rheumatica and arteritis temporalis. Inverse relationship between the acute hepatic phase reactants and the CD8+ T-cell subset.
    Elling H; Elling P; Olsson A
    Clin Exp Rheumatol; 1989; 7(6):627-30. PubMed ID: 2533002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis.
    Dasgupta B; Panayi GS
    Br J Rheumatol; 1990 Dec; 29(6):456-8. PubMed ID: 2124160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood dehydroepiandrosterone sulphate (DHEAS) levels in polymyalgia rheumatica/giant cell arteritis and primary fibromyalgia.
    Nilsson E; de la Torre B; Hedman M; Goobar J; Thörner A
    Clin Exp Rheumatol; 1994; 12(4):415-7. PubMed ID: 7955606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity.
    Grau RG; Kassan SS; Franks JJ; Kaplan H; Walker SH; Tan EM
    Ann Rheum Dis; 1984 Oct; 43(5):721-4. PubMed ID: 6497463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship of anti-endothelial cell antibodies to anti-phospholipid antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica.
    Le Tonquèze M; Dueymes M; Giovangrandi Y; Beigbeder G; Jouquan J; Pennec YL; Mottier D; Le Goff P; Youinou P
    Autoimmunity; 1995; 20(1):59-66. PubMed ID: 7578862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temporal arteritis after normalization of erythrocyte sedimentation rate in polymyalgia rheumatica.
    Papadakis MA; Schwartz ND
    Arch Intern Med; 1986 Nov; 146(11):2283-4. PubMed ID: 3778060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.
    Macchioni P; Boiardi L; Salvarani C; Rossi F; Casadei-Maldini M; Mancini R; Beltrandi E; Portioli I
    Br J Rheumatol; 1993 Aug; 32(8):666-70. PubMed ID: 8348267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica.
    Escribá A; Morales E; Albizúa E; Herrero JC; Ortuño T; Carreño A; Dominguez-Gil B; Praga M
    Am J Kidney Dis; 2000 Jan; 35(1):137-40. PubMed ID: 10620555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.
    Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implications of fever on erythrocyte sedimentation rate but not on C-reactive protein concentrations at the time of diagnosis of polymyalgia rheumatica. Comments on Betrains et al.
    Milchert M; Castagna A; Manzo C; Brzosko M
    Clin Exp Rheumatol; 2022 Mar; 40(3):667. PubMed ID: 34796849
    [No Abstract]   [Full Text] [Related]  

  • 55. A patient's diary.
    Ghose RR
    N Z Med J; 2005 Oct; 118(1224):U1718. PubMed ID: 16258587
    [No Abstract]   [Full Text] [Related]  

  • 56. [Polymyalgia rheumatica and giant cell arteritis].
    Jipp P; Fehring K
    Dtsch Med Wochenschr; 1984 Oct; 109(43):1635-8. PubMed ID: 6489177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Glycoregulation disorders in giant-cell arteritis].
    Kitschke B; Rodier M; Ciurana AJ; Orsetti A; Mirouze J
    Presse Med; 1985 Jun; 14(22):1221-4. PubMed ID: 3160017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Myalgia and high sedimentation rate in adults].
    Haga HJ; Johnsen V; Østensen M; Mikkelsen K; Gulseth HC; Kvien TK; Nordvåg BY
    Tidsskr Nor Laegeforen; 2000 Nov; 120(28):3405-8. PubMed ID: 11187194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Von Willebrand factor in the outcome of temporal arteritis.
    Cid MC; Monteagudo J; Oristrell J; Vilaseca J; Pallarés L; Cervera R; Font C; Font J; Ingelmo M; Urbano-Márquez A
    Ann Rheum Dis; 1996 Dec; 55(12):927-30. PubMed ID: 9014589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica.
    Rodriguez-Valverde V; Sarabia JM; González-Gay MA; Figueroa M; Armona J; Blanco R; Fernández-Sueiro JL; Martínez-Taboada VM
    Am J Med; 1997 Apr; 102(4):331-6. PubMed ID: 9217613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.